Dyne therapeutics patent
WebDyne Therapeutics is a biotechnology company which offers targeted therapies for patients with cardiac diseases, and serious and smooth muscle diseases. The Company … WebMay 16, 2024 · DYNE-101 is designed to enable targeted delivery to muscle tissue and address the genetic basis of the disease. The new data being presented during ASGCT evaluated monthly repeat doses of DYNE-101 ...
Dyne therapeutics patent
Did you know?
WebDoing Business As: Dyne Therapeutics Company Description: Key Principal: Joshua Brumm See more contacts Industry: Pharmaceutical preparations Printer Friendly View Address: 1560 Trapelo Rd Waltham, MA, 02451-7306 United States Phone: Website: www.dyne-tx.com Employees (this site): Actual Employees (all sites): Actual WebSep 1, 2024 · Dyne Therapeutics: ClinicalTrials.gov Identifier: NCT05524883 Other Study ID Numbers: DYNE251-DMD-201 2024-005478-24 ( EudraCT Number ) First Posted: September 1, 2024 Key Record Dates: Last Update Posted: March 27, 2024 Last Verified: March 2024 Individual Participant Data (IPD) Sharing Statement: ...
WebJan 18, 2024 · WALTHAM, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people... WebPatents and Trademarks by IPqwery. The intellectual property of Dyne Therapeutics includes 51 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' …
WebDyne Therapeutics, Inc. Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as … WebJul 1, 2024 · Using a similar approach, Dyne Therapeutics is developing the FORCE-DMPK ASO candidate, ... R.A. and M.P-G. are inventors in patents WO2016075285A1 and WO2016075288A1, currently licensed to Myogem Health Company. M.P-G. is a former member of the Board of Directors and shareholder of Myogem Health Company. A.L-C. …
WebDyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating fibrodysplasia ossificans progressiva US11168141B2 (en) 2024-08-02: 2024-11-09: …
WebJan 10, 2024 · Dyne is developing a broad portfolio of therapeutics for muscle diseases, including programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral... signification tarot chariotWebJan 20, 2024 · WALTHAM, Mass., Jan. 20, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 6,000,000 shares of its … the purple pig sacramentoWebMar 23, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to … the purple pillow carseatWebSep 6, 2024 · Dyne Therapeutics Announces First Patient Dosed in Phase 1/2 DELIVER Clinical Trial of DYNE-251 for the Treatment of Duchenne Muscular Dystrophy. … the purple pillow reviewsWebApr 3, 2024 · Catherine Stehman-Breen, M.D., Dyne’s chief medical officer, held senior leadership roles at Amgen and Regeneron Pharmaceuticals, and most recently served … the purple pie place custer sdWebSep 6, 2024 · Dyne has announced that the first participant has been dosed in the Phase 1/2 DELIVER clinical trial of DYNE-251 in participants with Duchenne amenable to skipping exon 51. Dyne -251 is an exon skipping product that combines a PMO to enable skipping of exon 51 with a fragment antibody (Fab) to increase targeted delivery of the product to ... signification thxWebApr 13, 2024 · Dyne Therapeutics Inc (DYN) stock is trading at $8.97 as of 3:43 PM on Thursday, Apr 13, a gain of $0.44, or 5.19% from the previous closing price of $8.53. The stock has traded between $8.49 and $9.15 so far today. Volume today is 467,568 compared to average volume of 400,449. signification tiktok